|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 10, 2015 ) Research Beam added report on Global HIV Drugs Market 2015 - 2019. About HIV, HIV is a type of retrovirus that causes infection in human beings. AIDS is a life-threatening disease caused by this virus. In this disease certain white blood cells (lymphocytes) are destroyed, resulting in the loss of the body's ability to protect itself against infections. The major route of transmission of HIV infection is unprotected sex, contaminated needle, breast milk, and infected blood. HIV attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. The anti-retroviral therapy is used to treat the patient and help the immune system fight the infection. This is mainly used to keep the level of the HIV low in the body.
Technavio's Analysts Forecast The Global HIV Drugs Market to Grow at a CAGR of 4.52% Over The Period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global HIV drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic and branded drugs and the expected launch of drug candidates used in the treatment of HIV infection.
Based on the class of drugs, the market is segmented as follows:
Multi-class combination products
Nucleoside reverse transcriptase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Protease inhibitors
Fusion inhibitors
Entry inhibitors - CCR5 co-receptor antagonist
HIV integrase strand transfer inhibitors
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
Technavio's report, Global HIV Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Other prominent vendors
AbbVie
AstraZeneca
Boehringer Ingelheim
Cipla
Daiichi Sankyo
Emcure
F. Hoffmann-La Roche
Hetero Drugs
Mylan
Pfizer
Shionogi
Teva Pharmaceutical Industries
Market driver
Inflow of funds
For a full, detailed list, view our report
Market challenge
Patent expiries
For a full, detailed list, view our report
Market trend
Increasing public awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENTS
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by drug class
PART 07: Global multi-class combination products market
Global multi-class combination products market
Enquiry @ http://www.researchbeam.com/global-hiv-drugs-2015-2019-market/enquire-about-report
About Us:
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.
Contact Us:
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/
Blog: http://www.researchbeam.blogspot.in/
Research Beam
James Jordan
+ 1-503-894-6022
james@researchbeam.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
